標(biāo)題: Titlebook: Nanomedicine; Emerging Prospects Subramanian Tamil Selvan Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive licens [打印本頁] 作者: Flexible 時間: 2025-3-21 19:47
書目名稱Nanomedicine影響因子(影響力)
書目名稱Nanomedicine影響因子(影響力)學(xué)科排名
書目名稱Nanomedicine網(wǎng)絡(luò)公開度
書目名稱Nanomedicine網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Nanomedicine被引頻次
書目名稱Nanomedicine被引頻次學(xué)科排名
書目名稱Nanomedicine年度引用
書目名稱Nanomedicine年度引用學(xué)科排名
書目名稱Nanomedicine讀者反饋
書目名稱Nanomedicine讀者反饋學(xué)科排名
作者: 脆弱么 時間: 2025-3-21 20:54 作者: lesion 時間: 2025-3-22 01:01 作者: Nefarious 時間: 2025-3-22 07:53 作者: 行業(yè) 時間: 2025-3-22 08:43 作者: nonplus 時間: 2025-3-22 13:47 作者: heartburn 時間: 2025-3-22 18:33
SpringerBriefs in Applied Sciences and Technologyhttp://image.papertrans.cn/n/image/660835.jpg作者: 鉗子 時間: 2025-3-22 22:20
https://doi.org/10.1007/978-981-99-2139-3Biocompatible nanoparticles; Cancer nanomedicine; Non-toxic nanoparticles; Smart theranostic; Nano/bioma作者: 瘋狂 時間: 2025-3-23 03:24 作者: 象形文字 時間: 2025-3-23 07:11
978-981-99-2138-6The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor作者: countenance 時間: 2025-3-23 11:57 作者: profligate 時間: 2025-3-23 14:17 作者: dilute 時間: 2025-3-23 20:07 作者: Jejune 時間: 2025-3-24 00:06
Nanomedicine for Neurodegenerative Diseases,r inhibiting the amyloid aggregation and tau hyperphosphorylation associated with the Alzheimer’s disease (AD). Different NP-based drug delivery approaches (e.g., apolipoprotein, peptides, dendrimers) to the delivery of CNS drugs across the blood–brain barrier (BBB) are discussed.作者: lethal 時間: 2025-3-24 06:01 作者: 飲料 時間: 2025-3-24 08:28
le by coordination as a six-electron ligand to two Fe atoms like in Fe.(CO).(μ-S=NH) [1]; see p. 2. Several quantum-chemical calculations using semiempirical and ab initio approaches have been performed; see Table 1. According to these studies, S=NH has a closed-shell 1.A’ ground state which is 1.02作者: 有毒 時間: 2025-3-24 14:43
Tamil Selvan Subramanian S.N. AsF. + 2 AsF.. This is the only route which gives high yields of a crystalline, soluble S.N. salt. The synthesis was carried out in flame-dried, three-bulb Pyrex glass vessels incorporating a medium sintered glass frit and closed with a Teflon-stemmed glass valve. It is important to use a well作者: HILAR 時間: 2025-3-24 15:18
Tamil Selvan Subramanianalysis (FDA) handles longitudinal data and treats each observation as a function of time (or other variable). The functions are related. The goal is to analyze a sample of functions instead of a sample of related points. ..FDA differs from traditional data analytic techniques in a number of ways. Fu作者: 細(xì)菌等 時間: 2025-3-24 20:58
Tamil Selvan Subramanianse from. The examples involving the clustering of Canadian weather stations are meant to be illustrative, since the known locations of weather stations can be used to infer which ones should exhibit similar weather patterns. The objective is not so much to find “real” clusters of stations, but rathe作者: 拋棄的貨物 時間: 2025-3-25 02:18
Tamil Selvan Subramanianse from. The examples involving the clustering of Canadian weather stations are meant to be illustrative, since the known locations of weather stations can be used to infer which ones should exhibit similar weather patterns. The objective is not so much to find “real” clusters of stations, but rathe作者: ARCH 時間: 2025-3-25 06:02
Introduction to Nanomedicine,pplication of nanomedicine in diagnostics and therapy of a wide range of diseases such as cancer, cardiovascular, orthopaedics, and neurodegenerative disorders. A wide range of nanomaterials, nanoparticles and biomaterials for these applications are discussed.作者: triptans 時間: 2025-3-25 08:36 作者: ITCH 時間: 2025-3-25 15:20
Nanomedicine for Neurodegenerative Diseases,r inhibiting the amyloid aggregation and tau hyperphosphorylation associated with the Alzheimer’s disease (AD). Different NP-based drug delivery approaches (e.g., apolipoprotein, peptides, dendrimers) to the delivery of CNS drugs across the blood–brain barrier (BBB) are discussed.作者: 水土 時間: 2025-3-25 18:05 作者: Entirety 時間: 2025-3-25 21:19
Nanomedicine for Cardiac Diseases,s and devices to diagnose, treat, and prevent a variety of cardiovascular diseases. The development of nanocarriers for drug delivery is a key application of nanomedicine in cardiology. This chapter delineates the applications of nanomedicine in diagnostics and treatment of cardiovascular diseases.作者: 轉(zhuǎn)向 時間: 2025-3-26 03:18 作者: 實(shí)現(xiàn) 時間: 2025-3-26 06:59
Cancer Nanomedicine,-, graphene-, graphene oxide- based nanocarriers, peptides or polymer mediated delivery vehicles, and liposomes for targeted delivery are discussed. Metallic nanostructures and plasmonic bimetallic nanocrystals and core–shell nanocomposites for combined photothermal-/chemo- or radio-/chemo-therapy are delineated.作者: Cholecystokinin 時間: 2025-3-26 12:24 作者: 小樣他閑聊 時間: 2025-3-26 15:19 作者: JOT 時間: 2025-3-26 17:01 作者: 絕食 時間: 2025-3-26 23:30
8樓作者: floaters 時間: 2025-3-27 03:20
8樓作者: forbid 時間: 2025-3-27 08:28
8樓作者: ELUDE 時間: 2025-3-27 13:07
9樓作者: CORD 時間: 2025-3-27 16:41
9樓作者: 依法逮捕 時間: 2025-3-27 17:46
9樓作者: Synapse 時間: 2025-3-28 00:52
9樓作者: Abrade 時間: 2025-3-28 06:04
10樓作者: 倒轉(zhuǎn) 時間: 2025-3-28 06:49
10樓作者: 道學(xué)氣 時間: 2025-3-28 13:34
10樓作者: 制定 時間: 2025-3-28 14:46
10樓
